抗吸收治疗疗效的药物遗传学：贝叶斯解释 - Suppr

Suppr

超能文献

Pharmacogenetics of anti-resorptive therapy efficacy: a Bayesian interpretation.

作者信息

Nguyen Tuan V

出版信息

Osteoporos Int. 2005 Aug;16(8):857-60. doi: 10.1007/s00198-004-1807-y. Epub 2005 Feb 1.

DOI:10.1007/s00198-004-1807-y

PMID:15685396

Abstract

摘要

相似文献

Pharmacogenetics of anti-resorptive therapy efficacy: a Bayesian interpretation.抗吸收治疗疗效的药物遗传学：贝叶斯解释

Osteoporos Int. 2005 Aug;16(8):857-60. doi: 10.1007/s00198-004-1807-y. Epub 2005 Feb 1.

The future of pharmacogenetics for osteoporosis.骨质疏松症的药物遗传学的未来。

Pharmacogenomics. 2013 Apr;14(6):641-53. doi: 10.2217/pgs.13.40.

Pharmacogenetics of osteoporosis: future perspectives.骨质疏松症的药物遗传学：未来展望。

Calcif Tissue Int. 2009 May;84(5):337-47. doi: 10.1007/s00223-009-9226-x. Epub 2009 Mar 7.

Osteoporosis pharmacogenomics: recent insights and future perspectives.

Pharmacogenomics. 2013 Apr;14(5):451-4. doi: 10.2217/pgs.13.9.

Pharmacogenetics of osteoporosis: towards novel theranostics for personalized medicine?骨质疏松症的药物遗传学：迈向个体化医学的新型治疗诊断方法？

OMICS. 2012 Dec;16(12):638-51. doi: 10.1089/omi.2011.0150.

Pharmacogenetics of osteoporosis.骨质疏松症的药物遗传学

Best Pract Res Clin Endocrinol Metab. 2014 Dec;28(6):783-93. doi: 10.1016/j.beem.2014.07.004. Epub 2014 Aug 12.

Pharmacogenomics of osteoporotic fractures.骨质疏松性骨折的药物基因组学

Methods Mol Biol. 2014;1175:661-70. doi: 10.1007/978-1-4939-0956-8_17.

Genetics and pharmacogenetics of osteoporosis.骨质疏松症的遗传学与药物遗传学

J Endocrinol Invest. 2005;28(10 Suppl):2-7.

Pharmacogenetics of bone treatments: the VDR and ERalpha gene story.骨治疗的药物遗传学：维生素D受体和雌激素受体α基因的故事

Pharmacogenomics. 2008 Jun;9(6):733-46. doi: 10.2217/14622416.9.6.733.

Pharmacogenomic approaches to osteoporosis.

Pharmacogenomics J. 2003;3(5):261-3. doi: 10.1038/sj.tpj.6500199.

引用本文的文献

Common methodological issues and suggested solutions in bone research.骨研究中的常见方法学问题及建议解决方案

Osteoporos Sarcopenia. 2020 Dec;6(4):161-167. doi: 10.1016/j.afos.2020.11.008. Epub 2020 Nov 28.

Post-GWAS Polygenic Risk Score: Utility and Challenges.全基因组关联研究后多基因风险评分：效用与挑战

JBMR Plus. 2020 Sep 19;4(11):e10411. doi: 10.1002/jbm4.10411. eCollection 2020 Nov.

Genetic profiling and individualized assessment of fracture risk.基因谱分析和骨折风险的个体化评估。

Nat Rev Endocrinol. 2013 Mar;9(3):153-61. doi: 10.1038/nrendo.2013.3. Epub 2013 Feb 5.

Genetics and the individualized prediction of fracture.遗传学与骨折的个体化预测。

Curr Osteoporos Rep. 2012 Sep;10(3):236-44. doi: 10.1007/s11914-012-0113-4.

本文引用的文献

BsmI vitamin D receptor genotypes influence the efficacy of antiresorptive treatments in postmenopausal osteoporotic women. A 1-year multicenter, randomized and controlled trial.BsmI维生素D受体基因型影响绝经后骨质疏松症女性抗吸收治疗的疗效。一项为期1年的多中心随机对照试验。

Osteoporos Int. 2005 Aug;16(8):943-52. doi: 10.1007/s00198-004-1800-5. Epub 2005 Mar 1.

Non-response to osteoporosis treatment.对骨质疏松症治疗无反应。

J Br Menopause Soc. 2004 Jun;10(2):76-80. doi: 10.1258/136218004774202409.

The new math of clinical trials.临床试验的新数学方法。

Science. 2004 Feb 6;303(5659):784-6. doi: 10.1126/science.303.5659.784.

Pharmacogenetics: potential for individualized drug therapy through genetics.药物遗传学：通过遗传学实现个体化药物治疗的潜力。

Trends Genet. 2003 Nov;19(11):660-6. doi: 10.1016/j.tig.2003.09.008.

Effectiveness of alendronate treatment in postmenopausal women with osteoporosis: relationship with BsmI vitamin D receptor genotypes.阿仑膦酸盐治疗绝经后骨质疏松症妇女的疗效：与维生素D受体基因BsmI多态性的关系

Clin Endocrinol (Oxf). 2003 Mar;58(3):365-71. doi: 10.1046/j.1365-2265.2003.01724.x.

Replication validity of genetic association studies.基因关联研究的复制有效性

Nat Genet. 2001 Nov;29(3):306-9. doi: 10.1038/ng749.

Pharmacogenetics of the vitamin D receptor and osteoporosis.维生素D受体与骨质疏松症的药物遗传学

Drug Metab Dispos. 2001 Apr;29(4 Pt 2):505-12.

Sifting the evidence-what's wrong with significance tests?筛选证据——显著性检验存在哪些问题？

BMJ. 2001 Jan 27;322(7280):226-31. doi: 10.1136/bmj.322.7280.226.

Advances in pharmacogenetics and pharmacogenomics.药物遗传学和药物基因组学的进展。

J Clin Pharmacol. 2000 Sep;40(9):930-8. doi: 10.1177/00912700022009666.

Bayesian communication: a clinically significant paradigm for electronic publication.贝叶斯通信：电子出版的一种具有临床意义的范式。

J Am Med Inform Assoc. 2000 May-Jun;7(3):254-66. doi: 10.1136/jamia.2000.0070254.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验